PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
| NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
| Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
| DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
| RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
| DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
| BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
| Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
| Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
| Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |